Ph1 study of ABBV-383 in subjects with relapsed or refractory MM
Phase
Phase I Clinical Trial
Trial Number
05650632
Trial Status
OPEN
Study Overview
A Multicenter Phase 1b Open-label Study to Evaluate Dose Optimization Measures and Safety of ABBV-383 in Subjects with Relapsed or Refractory Multiple Myeloma (M24-108)
